Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge?

Sharma A, Loewenstein A, Parachuri N, Kumar N, Rasal A, Bandello F, Kuppermann BD

Open source

DOI
10.1038/s41433-023-02698-3
Published
2024 Feb
Container
Eye (London, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41433-023-02698-3,
  title = {Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge?},
  author = {Sharma A and Loewenstein A and Parachuri N and Kumar N and Rasal A and Bandello F and Kuppermann BD},
  year = {2024},
  journal = {Eye (London, England)},
  doi = {10.1038/s41433-023-02698-3},
  url = {https://doi.org/10.1038/s41433-023-02698-3}
}

RIS

TY  - JOUR
TI  - Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge?
AU  - Sharma A
AU  - Loewenstein A
AU  - Parachuri N
AU  - Kumar N
AU  - Rasal A
AU  - Bandello F
AU  - Kuppermann BD
PY  - 2024
JO  - Eye (London, England)
DO  - 10.1038/s41433-023-02698-3
UR  - https://doi.org/10.1038/s41433-023-02698-3
ER  - 

APA

A, S., A, L., N, P., N, K., A, R., F, B., & BD, K. (2024). Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge?. Eye (London, England). https://doi.org/10.1038/s41433-023-02698-3

Source records